Top compounds associated with response to BHLHB9


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.2
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.062 0.2
mRNA WAY-362450 CTRPv2 pan-cancer AAC 0.056 0.2
mRNA alisertib CTRPv2 pan-cancer AAC 0.046 0.2
mRNA pac-1 GDSC1000 pan-cancer AAC -0.056 0.2
mRNA MI-1 CTRPv2 pan-cancer AAC 0.058 0.2
mRNA CGP-60474 GDSC1000 pan-cancer AAC -0.088 0.2
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.2
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC 0.055 0.2
mRNA DBeQ CTRPv2 pan-cancer AAC 0.053 0.2
Download CSV